头盔式无创通气与面罩无创通气及经鼻高流量氧疗在急性呼吸衰竭中的比较:系统综述与荟萃分析
该系统综述与荟萃分析纳入16项RCT(n=949)和8项观察性研究(n=396),比较头盔式无创通气与面罩无创通气或经鼻高流量氧疗在急性呼吸衰竭中的效果。与面罩无创通气相比,基于低确定性证据,头盔式无创通气可能降低死亡率和插管率,对无创通气时长无影响;与经鼻高流量氧疗相比,头盔式无创通气可能降低插管率,但对死亡率的影响不确定。
要点
- 与面罩无创通气相比,头盔式无创通气可能降低死亡率和插管率(低确定性证据)。
- 头盔式无创通气对无创通气时长无影响,对ICU住院时长和压疮的影响不确定。
- 与经鼻高流量氧疗相比,头盔式无创通气可能降低插管率,但对死亡率的影响不确定。
核心结论
- 与面罩无创通气相比,头盔式无创通气可能降低死亡率和插管率,但对无创通气时长无影响。
- 与经鼻高流量氧疗相比,头盔式无创通气可能降低插管率,但对死亡率的影响不确定。
研究设计与样本
- 系统综述与荟萃分析,检索多个数据库识别RCT和观察性研究。
- 纳入16项RCT(n=949)和8项观察性研究(n=396),分别合并数据。
- 使用Cochrane RoB 2工具评估RCT偏倚风险,Ottawa-Newcastle量表评估观察性研究,GRADE框架评级证据确定性。
主要发现
- 与面罩无创通气相比,头盔式无创通气可能降低死亡率(RR 0.56,95%CI 0.33-0.95;低确定性证据)。
- 与面罩无创通气相比,头盔式无创通气可能降低插管率(RR 0.35,95%CI 0.22-0.56;低确定性证据),在低氧血症和高碳酸血症呼吸衰竭中均如此。
- 头盔式无创通气对无创通气时长可能无影响;对ICU住院时长和压疮发生的影响不确定。
- 观察性研究数据与上述发现一致,但确定性更低。
- 与经鼻高流量氧疗相比,基于低和极低确定性数据,头盔式无创通气可能降低插管率,但对死亡率的影响不确定。
临床怎么用
- 在急性呼吸衰竭患者中,可考虑使用头盔式无创通气以降低死亡率和插管风险,尤其在与面罩无创通气比较时。
- 与经鼻高流量氧疗相比,头盔式无创通气可能降低插管率,但死亡率获益不确定,需结合临床情况选择。
- 证据确定性多为低或极低,临床决策应个体化并考虑患者耐受性和资源条件。
局限性
- 纳入研究数量有限,部分结局证据确定性低或极低。
- 观察性研究数据确定性更低,可能存在混杂偏倚。
- 头盔式无创通气对ICU住院时长和压疮等结局的影响不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although small randomised controlled trials (RCTs) and observational studies have examined helmet noninvasive ventilation (NIV), uncertainty remains regarding its role. We conducted a systematic review and meta-analysis to examine the effect of helmet NIV compared to facemask NIV or high-flow nasal cannula (HFNC) in acute respiratory failure. METHODS: We searched multiple databases to identify RCTs and observational studies reporting on at least one of mortality, intubation, intensive care unit (ICU) length of stay, NIV duration, complications or comfort with NIV therapy. We assessed study risk of bias using the Cochrane Risk of Bias 2 tool for RCTs and the Ottawa-Newcastle Scale for observational studies, and rated certainty of pooled evidence using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) framework. RESULTS: We separately pooled data from 16 RCTs (n=949) and eight observational studies (n=396). Compared to facemask NIV, based on low certainty of evidence, helmet NIV may reduce mortality (relative risk 0.56, 95% CI 0.33-0.95) and intubation (relative risk 0.35, 95% CI 0.22-0.56) in both hypoxic and hypercapnic respiratory failure, but may have no effect on duration of NIV. There was an uncertain effect of helmet NIV on ICU length of stay and development of pressure sores. Data from observational studies were consistent with the foregoing findings but of lower certainty. Based on low and very low certainty data, helmet NIV may reduce intubation compared to HFNC, but its effect on mortality is uncertain. CONCLUSIONS: Compared to facemask NIV, helmet NIV may reduce mortality and intubation; however, the effect of helmet NIV compared to HFNC remains uncertain.
引用
- Chaudhuri D, Jinah R, Burns KEA, et al. Helmet noninvasive ventilation compared to facemask noninvasive ventilation and high-flow nasal cannula in acute respiratory failure: a systematic review and meta-analysis. Eur Respir J. 2022. PMID: 34413155. doi:10.1183/13993003.01269-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。